The prevalence and incidence, resource use and financial costs of treating people with attention deficit/hyperactivity disorder (ADHD) in the United Kingdom (1998 to 2010)

被引:63
作者
Holden, Sarah E. [1 ]
Jenkins-Jones, Sara [2 ]
Poole, Chris D. [1 ]
Morgan, Christopher L. L. [2 ]
Coghill, David [3 ]
Currie, Craig J. [1 ]
机构
[1] Cardiff Univ, Pharma Res Ctr, Primary Care & Publ Hlth, Sch Med,Cardiff Medictr, Cardiff CF14 4UJ, S Glam, Wales
[2] Cardiff Medictr, Pharmatelligence, Global Epidemiol, Cardiff CF14 4UJ, S Glam, Wales
[3] Univ Dundee, Med Res Inst, Div Neurosci, Dundee DD1 9SY, Scotland
关键词
ADHD; CPRD; Prevalence; Incidence; Healthcare cost; DEFICIT-HYPERACTIVITY DISORDER; EXCESS COSTS; CHILDREN; CARE; ADOLESCENTS; COMORBIDITY; BARRIERS; FAMILY; LIFE;
D O I
10.1186/1753-2000-7-34
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: Attention deficit/hyperactivity disorder (ADHD) is a common disorder that often presents in childhood and is associated with increased healthcare resource use. The aims of this study were to characterise the epidemiology of diagnosed ADHD in the UK and determine the resource use and financial costs of care. Methods: For this retrospective, observational cohort study, patients newly diagnosed with ADHD between 1998 and 2010 were identified from the UK Clinical Practice Research Datalink (CPRD) and matched to a randomly drawn control group without a diagnosis of ADHD. The prevalence and incidence of diagnosed ADHD were calculated. Resource utilisation and corresponding financial costs post-diagnosis were estimated for general practice contacts, investigations, prescriptions, outpatient appointments, and inpatient admissions. Results: Incidence of diagnosed ADHD (and percentage change using 1998 as a reference) increased from 6.9 per 100,000 population in 1998 to 12.2 per 100,000 (78%) in 2007 and then fell to 9.9 per 100,000 (44%) by 2009. The corresponding prevalence figures were 30.5, 88.9 (192%) and 81.5 (167%) per 100,000. Incidence and prevalence were higher in males than females. Mean annual total healthcare costs were higher for ADHD cases than controls (1,327 pound versus 328 pound for year 1, 1,196 pound vs. 337 pound for year 2, 1,148 pound vs. 316 pound for year 3, 1,126 pound vs. 325 pound for year 4, and 1,112 pound vs. 361 pound for year 5). Conclusions: The prevalence of diagnosed ADHD in routine practice in the UK was notably lower than in previous reports, and both prevalence and incidence of diagnosed ADHD in primary care have fallen since 2007. Financial costs were more than four times higher in those with ADHD than in those without ADHD.
引用
收藏
页数:13
相关论文
共 38 条
[1]  
[Anonymous], 2011, PRESCRIPTIONS COST A
[2]  
[Anonymous], 2010, HOSP PRESCRIBING
[3]  
[Anonymous], 2010, PRESCRIPTION COST AN
[4]  
[Anonymous], DIAGN MAN ADHD CHILD
[5]  
[Anonymous], 2011, UNIT COSTS HLTH SOCI
[6]   Attention-deficit hyperactivity disorder and problems in peer relations: Predictions from childhood to adolescence [J].
Bagwell, CL ;
Molina, BSG ;
Pelham, WE ;
Hoza, B .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2001, 40 (11) :1285-1292
[7]  
BERRY CA, 1985, PEDIATRICS, V76, P801
[8]   Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000 [J].
Birnbaum, HG ;
Kessler, RC ;
Lowe, SW ;
Secnik, K ;
Greenberg, PE ;
Leong, SA ;
Swensen, AR .
CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (02) :195-205
[9]   Health care use and costs for children with attention-deficit/hyperactivity disorder - National estimates front the Medical Expenditure Panel Survey [J].
Chan, E ;
Zhan, CL ;
Homer, CJ .
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2002, 156 (05) :504-511
[10]  
Committee on Safety of Medicines and Medicines Control Agency, 1997, CURRENT PROBLEMS PHA, V23, P10